跳至主要内容
临床试验/NCT07113132
NCT07113132尚未招募不适用

Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia

Safaa Ali0 个研究点目标入组 84 人开始时间: 2025年8月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
84
主要终点
2-To determine the effect of presence of SF3B1-K700E mutation with other laboratory findings.

研究概览

简要总结

aim of the work

  1. To evaluate the presence of SF3B1-K700E mutation in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
  2. To determine the correlation between the presence of SF3B1-K700E mutation with other laboratory findings.

详细描述

Leukemia is one of the deadliest diseases having negative impact on people all over the world. Acute Lymphocytic Leukemia (ALL) is a type of WBC cancer, it's a rapidly invasive disease that originates from B- or T-lymphocyte progenitors. Accumulation of lymphoblasts and suppression of normal cells are the main characteristics of the disease course .

Acute lymphoblastic leukemia (ALL) predominantly affects children, with an incidence of 3-4/100,000 in patients under 14 years of age. The five-year survival rate is approximately 90% in children and 65% in adults .

The French-American-British (FAB) categorizes ALL into three subtypes However, the WHO classification incorporates immunophenotypic and genetic details, offering a more accurate and clinically significant classification, helping to choose therapies and prognostic evaluations according to the distinct characteristics of leukemia. Medical professionals have recently recommended that WHO categorization is better compared to FAB .

Chronic lymphoproliferative diseases (CLPD) are considered as a heterogeneous group of diseases characterized by monoclonal expansion and accumulation of apparently mature lymphocytes, which have a proliferative and/or survival advantage over normal lymphocytes in different organs such as bone marrow, peripheral blood and lymph nodes. This translates into the progressive accumulation of clonal cells and their products, causing peripheral blood and bone marrow lymphocytosis, in addition to lymphadenopathy, splenomegaly or other organomegaly .

Recently, mutations in the genes involved in the spliceosome have attracted considerable interest in different neoplasms. Among the spliceosome mutations, those in the SF3B1 gene are the most frequent and relevant in haematological diseases. Most human genes encode several mRNA isoforms by the alternative splicing process. Because alternatively spliced mRNA isoforms are often associated with cancer, spliceosome mutations have recently sparked significant interest in different neoplasms .

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with acute lymphocytic leukemia or chronic lymphocytic leukemia of both genders at any age.

排除标准

  • Patients with any other type of malignancies

结局指标

主要结局

2-To determine the effect of presence of SF3B1-K700E mutation with other laboratory findings.

时间窗: two years

determine if the presence of SF3B1-mutation can affect the clinical data as severity of disease or organomegaly and laboratory data as count of white blood cells and platalet and hemoglobin level using automated cbc analyser and bone marrow of the patients (cellularity and count of blast cells) and result of flow cytometry

1- To evaluate the presence of SF3B1-K700E mutation in acute lymphoblastic leukemia and chronic lymphocytic leukemia using PCR technique

时间窗: 2 years

ARMS PCR technique will be used to detect the presence of SF3B1-MUTATION in acute lymphoblastic leukemia and chronic lymphocytic leukemia

次要结局

未报告次要终点

研究者

发起方
Safaa Ali
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Safaa Ali

assisstant lecturer

Assiut University

相似试验